$5650 | Single User
$6650 | Multi User
$8150 | Corporate License
$10000 | Site License

Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022
[Lowest Price Guaranteed: $5,650]

Published by MarketsandMarkets: 24 Aug 2017 | 127826 | In Stock

Introduction

“Global next-generation sequencing (NGS) services market projected to grow at a CAGR of 21.0%”

The global next-generation sequencing (NGS) services market is expected to reach USD 2,748.6 million by 2022 from USD 1,059.2 million in 2017; growing at a CAGR of 21.0% during the forecast period. Factors such as declining price of sequencing, the high cost of sequencing infrastructure, the need for skilled professionals for efficient NGS sample preparation and analysis, and technological advancements in the field of sequencing are driving the growth of this market. However, installation of in-house sequencing facilities in hospitals and universities is expected to limit the optimal market growth for NGS services during the forecast period

“Targeted resequencing & custom gene panels are expected to grow at the highest CAGR during 2017 to 2022”

By type, the global NGS services market covers targeted resequencing & custom gene panels, RNA-Seq, de novo sequencing, exome sequencing, CHiP-Seq, whole-genome sequencing, methyl-seq, and other services. The targeted resequencing & custom gene panels segment is expected to grow at the highest CAGR during 2017 to 2022. Targeted sequencing/gene panels allow researchers to focus on the subset of genes or region, which reduces the time consumed for sequencing, the cost of sequencing, and simplifies data analysis.

“Sequencing by synthesis technology to dominate the global NGS services market during the forecast period”

By technology, the NGS services market is segmented into sequencing by synthesis (SBS), ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing. The SBS segment is estimated to account for the largest share of the NGS services market in 2017. The introduction of technologically advanced SBS platforms and decreasing cost of sequencing are the major factors driving the growth of the SBS segment.

“APAC is projected to witness the highest growth during the forecast period “

While North America accounted for the largest share of the market in 2016, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022. This is owing to increasing incidence of target diseases, rising awareness regarding the benefits of NGS-based clinical applications, and growing research activity in the region.

Breakdown of supply-side primary interviews: by company type, designation, and region:

• By Company Type - Tier 1 –31%, Tier 2 –48% and Tier 3 –21%

• By Designation – C level – 26%, Director level – 24%, Others – 50%

• By Region – North America – 29%, Europe – 35%, APAC – 21%, RoW – 15%

As of 2016, major players operating in the global NGS services market are BGI (China), Eurofins Scientific SE (Luxembourg), PerkinElmer, Inc. (U.S.), QIAGEN (Germany), Macrogen Inc. (South Korea), GENEWIZ, Inc. (U.S.), Illumina, Inc. (U.S.), Novogene Corporation (China), and GATC Biotech AG (Germany) among others.

Research Coverage

This report studies the NGS services market-based on type, technology, application, and end user. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of market segments with respect to four main regions.

Reasons to Buy the Report:

This research focuses on various levels of analysis—competitive leadership analysis of 25 market players, and company profiles of top 15 market players—which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the NGS services market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on business strategies adopted by the major players in the NGS services market. The report analyzes the NGS services market-based on types, technology, application, end user, and region.

• Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and product & service launches in the NGS services.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various NGS services across geographies.

• Market Diversification: Exhaustive information about new NGS services, untapped geographies, recent developments, and investments in the NGS services market.

• Competitive Assessment: In-depth assessment of market ranking, strategies, products and services, and sequencing capabilities of leading players in the NGS services market.

Table of Contents
for Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022

  • TABLE OF CONTENTS

    1 INTRODUCTION 14

    1.1 OBJECTIVES OF THE STUDY 14

    1.2 MARKET DEFINITION 14

    1.2.1 MARKETS COVERED 15

    1.2.2 YEARS CONSIDERED FOR THE STUDY 15

    1.3 CURRENCY 16

    1.4 STAKEHOLDERS 16

    2 RESEARCH METHODOLOGY 17

    2.1 RESEARCH APPROACH 17

    2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 19

    2.2.1 SECONDARY RESEARCH 19

    2.2.1.1 Key data from secondary sources 19

    2.2.2 PRIMARY DATA 20

    2.2.2.1 Breakdown of primaries 20

    2.2.2.2 Key data from primary sources 21

    2.2.2.3 Key industry insights 22

    2.3 MARKET SIZE ESTIMATION 23

    2.3.1 BOTTOM-UP APPROACH 23

    2.3.2 TOP-DOWN APPROACH 24

    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 25

    2.5 ASSUMPTIONS FOR THE STUDY 26

    3 EXECUTIVE SUMMARY 27

    4 PREMIUM INSIGHTS 31

    4.1 NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET OVERVIEW 31

    4.2 GLOBAL NGS SERVICES MARKET, BY TYPE, 2015 VS. 2017 VS. 2022 (USD MILLION) 32

    4.3 GEOGRAPHIC ANALYSIS: NGS SERVICES MARKET, BY TECHNOLOGY (2017) 32

    4.4 NGS SERVICES MARKET, BY APPLICATION 33

    4.5 GLOBAL NGS SERVICES MARKET, BY END USER, 2017 VS. 2022 33

    4.6 GEOGRAPHICAL SNAPSHOT OF THE NGS SERVICES MARKET 34

    5 MARKET OVERVIEW 35

    5.1 INTRODUCTION 36

    5.2 MARKET DYNAMICS 36

    5.2.1 DRIVERS 37

    5.2.1.1 Declining price of sequencing 37

    5.2.1.2 High cost of sequencing infrastructure 38

    5.2.1.3 Need for skilled professionals for efficient NGS sample preparation and analysis 38

    5.2.1.4 Sequencing services, the preferred option for NGS applications with low throughput requirements 38

    5.2.1.5 Technological advancements in the field of sequencing 39

    5.2.2 RESTRAINTS 39

    5.2.2.1 Installation of in-house sequencing facilities in hospitals and universities 39

    5.2.3 OPPORTUNITIES 39

    5.2.3.1 Analysis of complex sequencing data 39

    5.2.3.2 Increasing applications in cancer and agrigenomics research 40

    5.2.4 CHALLENGES 40

    5.2.4.1 Accuracy & standardization concerns in diagnostic testing 40

    5.2.4.2 Ethical issues related to NIPT 41

    6 GLOBAL NEXT-GENERATION SEQUENCING SERVICES MARKET,

    BY TECHNOLOGY 42

    6.2 INTRODUCTION 43

    6.3 SEQUENCING BY SYNTHESIS 44

    6.4 ION SEMICONDUCTOR SEQUENCING 45

    6.5 SINGLE-MOLECULE REAL-TIME SEQUENCING 46

    6.6 NANOPORE SEQUENCING 47

    7 GLOBAL NGS SERVICES MARKET, BY SERVICE TYPE 49

    7.1 INTRODUCTION 50

    7.2 TARGETED RESEQUENCING & CUSTOM GENE PANELS 51

    7.3 RNA-SEQ 52

    7.4 DE NOVO SEQUENCING 53

    7.5 EXOME SEQUENCING 54

    7.6 CHIP-SEQ 55

    7.7 WHOLE-GENOME SEQUENCING 56

    7.8 METHYL-SEQ 57

    7.9 OTHER SERVICES 58

    8 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION 59

    8.1 INTRODUCTION 60

    8.2 DIAGNOSTICS 61

    8.2.1 ONCOLOGY 63

    8.2.2 INFECTIOUS DISEASES 64

    8.2.3 RARE GENETIC DISORDERS 64

    8.2.4 REPRODUCTIVE HEALTH 65

    8.2.5 OTHER DIAGNOSTIC APPLICATIONS 65

    8.3 DRUG DISCOVERY 66

    8.4 BIOMARKER DISCOVERY 67

    8.5 AGRICULTURE & ANIMAL RESEARCH 69

    8.6 OTHER APPLICATIONS 70

    9 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER 72

    9.1 INTRODUCTION 73

    9.1.1 ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS 74

    9.1.2 HOSPITALS & CLINICS 75

    9.1.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 76

    9.1.4 OTHER END USERS 77

    10 GLOBAL NEXT-GENERATION SEQUENCING SERVICES MARKET, BY REGION 78

    10.1 INTRODUCTION 79

    10.2 NORTH AMERICA 80

    10.2.1 U.S. 84

    10.2.2 CANADA 85

    10.3 EUROPE 86

    10.3.1 GERMANY 90

    10.3.2 U.K. 91

    10.3.3 FRANCE 91

    10.3.4 REST OF EUROPE 92

    10.4 ASIA-PACIFIC 93

    10.4.1 CHINA 97

    10.4.2 JAPAN 98

    10.4.3 INDIA 99

    10.4.4 REST OF ASIA-PACIFIC 100

    10.5 REST OF THE WORLD 101

    11 COMPETITIVE LANDSCAPE 105

    11.1 INTRODUCTION 105

    11.2 MARKET RANKING ANALYSIS 105

    11.3 COMPETITIVE LEADERSHIP BENCHMARKING 106

    11.3.1 VISIONARY LEADERS 106

    11.3.2 INNOVATORS 106

    11.3.3 DYNAMIC DIFFERENTIATORS 106

    11.3.4 EMERGING COMPANIES 106

    11.4 STRENGTH OF PRODUCT PORTFOLIO (FOR 25 PLAYERS) 108

    11.5 BUSINESS STRATEGY EXCELLENCE (FOR 25 PLAYERS) 109

    *Top 25 companies analyzed for this study are - Illumina, Inc., BGI, Eurofins Scientific SE, PerkinElmer, Inc., QIAGEN N.V., GATC Biotech AG, Macrogen Inc., DNA Link, Inc, Genotypic Technology Pvt Ltd, WuXi AppTec, GENEWIZ, Inc., Takara Bio Inc., SciGenom Labs Pvt. Ltd, Theragen Etex Co., Ltd., LGC Genomics Limited, Oxford Gene Technology, Sysmex Corporation, Genomics BioSci & Tech. Co., Ltd., Zymo Research Corp, Source BioScience, IntegraGen SA, CENTOGENE AG, Otogenetics Corporation, Novogene Corporation, Personalis, Inc.

    12 COMPANY PROFILES 110

    12.1 INTRODUCTION 110

    (OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS.)*

    12.2 BGI 110

    12.3 ILLUMINA, INC. 113

    12.4 PERKINELMER, INC. 116

    12.5 EUROFINS SCIENTIFIC SE 119

    12.6 GATC BIOTECH AG 122

    12.7 MACROGEN, INC. 125

    12.8 QIAGEN N.V. 127

    12.9 GENOTYPIC TECHNOLOGY PVT. LTD. 130

    12.10 GENEWIZ, INC. 132

    12.11 DNA LINK, INC. 134

    12.12 TAKARA BIO INC. (PART OF TAKARA HOLDING COMPANY INC.) 136

    12.13 SCIGENOM LABS PVT. LTD 139

    12.14 NOVOGENE CORPORATION 141

    12.15 PERSONALIS, INC. 143

    12.16 LGC LIMITED (A PART OF KKR & CO. L.P.) 145

    *Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.

    13 APPENDIX 147

    13.1 DISCUSSION GUIDE 147

    13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 152

    13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 154

    13.4 AVAILABLE CUSTOMIZATIONS 155

    13.5 RELATED REPORTS 156

    13.6 AUTHOR DETAILS 157

List Of Tables
in Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022

LIST OF TABLES


TABLE 1 NGS SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 44

TABLE 2 NGS SERVICES MARKET FOR SEQUENCING BY SYNTHESIS, BY REGION,

2015–2022 (USD MILLION) 45

TABLE 3 NGS SERVICES MARKET FOR ION SEMICONDUCTOR SEQUENCING, BY REGION, 2015–2022 (USD MILLION) 46

TABLE 4 NGS SERVICES MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING,

BY REGION, 2015–2022 (USD MILLION) 47

TABLE 5 NGS SERVICES MARKET FOR NANOPORE SEQUENCING, BY REGION,

2015–2022 (USD MILLION) 48

TABLE 6 NGS SERVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 50

TABLE 7 TARGETED SEQUENCING SERVICES MARKET, BY REGION,

2015–2022 (USD MILLION) 51

TABLE 8 RNA-SEQ SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 53

TABLE 9 DE NOVO SEQUENCING SERVICES MARKET, BY REGION,

2015–2022 (USD MILLION) 54

TABLE 10 EXOME SEQUENCING SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 55

TABLE 11 CHIP-SEQ SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 56

TABLE 12 WHOLE-GENOME SEQUENCING SERVICES MARKET, BY REGION,

2015–2022 (USD MILLION) 57

TABLE 13 METHYL-SEQ SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 58

TABLE 14 OTHER NGS SERVICES MARKET, BY REGION, 2015–2022 (USD MILLION) 58

TABLE 15 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION,

2015–2022 (USD MILLION) 60

TABLE 16 NGS DIAGNOSTIC SERVICES MARKET, BY APPLICATION,

2015–2022 (USD MILLION) 62

TABLE 17 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 63

TABLE 18 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR DRUG DISCOVERY,

BY REGION, 2015–2022 (USD MILLION) 67

TABLE 19 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR BIOMARKER DISCOVERY, BY REGION, 2015–2022 (USD MILLION) 69

TABLE 20 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR AGRICULTURE AND ANIMAL RESEARCH, BY REGION, 2015–2022 (USD MILLION) 70

TABLE 21 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR OTHER APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 71

TABLE 22 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER,

2015–2022 (USD MILLION) 73

TABLE 23 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS, BY REGION,

2015–2022 (USD MILLION) 75

TABLE 24 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2015–2022 (USD MILLION) 76

TABLE 25 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2015–2022 (USD MILLION) 77

TABLE 26 NEXT-GENERATION SEQUENCING SERVICES MARKET FOR OTHER END USERS,

BY REGION, 2015–2022 (USD MILLION) 77

TABLE 27 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY REGION,

2015–2022 (USD MILLION) 80

TABLE 28 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET,

BY COUNTRY, 2015–2022 (USD MILLION) 81

TABLE 29 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 82

TABLE 30 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET,

BY TECHNOLOGY, 2015–2022 (USD MILLION) 82

TABLE 31 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET,

BY APPLICATION, 2015–2022 (USD MILLION) 83

TABLE 32 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET,

BY END USER, 2015–2022 (USD MILLION) 83

TABLE 33 U.S.: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 84

TABLE 34 CANADA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 85

TABLE 35 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION) 88

TABLE 36 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE,

2015–2022 (USD MILLION) 88

TABLE 37 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 89

TABLE 38 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 89

TABLE 39 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 90

TABLE 40 GERMANY: NEXT-GENERATION SEQUENCING SERVICES MARKET,

BY TECHNOLOGY, 2015–2022 (USD MILLION) 90

TABLE 41 U.K.: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 91

TABLE 42 FRANCE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 92

TABLE 43 ROE: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 92

TABLE 44 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET,

BY COUNTRY, 2015–2022 (USD MILLION) 95

TABLE 45 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2015–2022 (USD MILLION) 95

TABLE 46 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET,

BY TECHNOLOGY, 2015–2022 (USD MILLION) 96

TABLE 47 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET,

BY APPLICATION, 2015–2022 (USD MILLION) 96

TABLE 48 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER, 2015–2022 (USD MILLION) 97

TABLE 49 CHINA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 98

TABLE 50 JAPAN: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 98

TABLE 51 INDIA: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 99

TABLE 52 ROAPAC: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 100

TABLE 53 ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE,

2015–2022 (USD MILLION) 103

TABLE 54 ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 103

TABLE 55 ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 104

TABLE 56 ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER,

2015–2022 (USD MILLION) 104

List Of Figures, Charts and Diagrams
in Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022

LIST OF FIGURES


FIGURE 1 GLOBAL NGS SERVICES MARKET: RESEARCH APPROACH 17

FIGURE 2 RESEARCH DESIGN 18

FIGURE 3 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 20

FIGURE 4 NGS SERVICES MARKET: BOTTOM-UP APPROACH 23

FIGURE 5 NGS SERVICES MARKET: TOP-DOWN APPROACH 24

FIGURE 6 NGS SERVICES MARKET: DATA TRIANGULATION 25

FIGURE 7 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TYPE, 2017 VS. 2022 27

FIGURE 8 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY TECHNOLOGY,

2017 VS. 2022 (USD MILLION) 28

FIGURE 9 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY APPLICATION,

2017 VS. 2022 (USD MILLION) 28

FIGURE 10 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY END USER,

2017 VS. 2022 (USD MILLION) 29

FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE NEXT-GENERATION SEQUENCING SERVICES MARKET 30

FIGURE 12 INCREASING APPLICATIONS OF NGS IN CANCER AND AGRIGENOMICS RESEARCH TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 31

FIGURE 13 NORTH AMERICA TO DOMINATE THE NGS SERVICES MARKET IN 2017 32

FIGURE 14 AGRICULTURE & ANIMAL RESEARCH SEGMENT TO REGISTER THE HIGHEST GROWTH RATE IN THE NGS SERVICES MARKET BETWEEN 2017 & 2022 33

FIGURE 15 ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL NGS SERVICES MARKET IN 2022 33

FIGURE 16 ASIA-PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 34

FIGURE 17 NEXT-GENERATION SEQUENCING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 36

FIGURE 18 HUMAN WHOLE-GENOME SEQUENCING COST ESTIMATED BY THE NATIONAL HUMAN GENOME RESEARCH INSTITUTE 37

FIGURE 19 NANOPORE SEQUENCING TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2017 TO 2022) 43

FIGURE 20 NGS SERVICES MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION) 43

FIGURE 21 TARGETED RESEQUENCING/CUSTOM GENE PANELS SEGMENT WILL

CONTINUE TO DOMINATE THE GLOBAL NEXT-GENERATION SEQUENCING

SERVICES MARKET IN 2022 50

FIGURE 22 DIAGNOSTICS SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL NEXT-GENERATION SEQUENCING SERVICES MARKET IN 2022 61

FIGURE 23 GROWTH IN NUMBER OF GENETIC TESTS (2012–2016) 62

FIGURE 24 INCREASING PUBLICATIONS RELATED TO BIOMARKER DISCOVERY BASED ON NGS DURING 2011-2016 67

FIGURE 25 ACADEMIC & GOVERNMENT INSTITUTES AND RESEARCH CENTERS TO REGISTER THE HIGHEST CAGR IN THE FORECAST PERIOD 73

FIGURE 26 NEXT-GENERATION SEQUENCING SERVICES MARKET, BY REGION 79

FIGURE 27 NORTH AMERICA: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT 81

FIGURE 28 EUROPE: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT 87

FIGURE 29 ASIA-PACIFIC: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT 94

FIGURE 30 ROW: NEXT-GENERATION SEQUENCING SERVICES MARKET SNAPSHOT 102

FIGURE 31 BGI, EUROFINS SCIENTIFIC SE, AND MACROGEN WERE THE LEADING PROVIDERS FOR NGS SERVICES WORLDWIDE IN 2016 105

FIGURE 32 NGS SERVICES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2017 107

FIGURE 33 ILLUMINA, INC.: COMPANY SNAPSHOT (2016) 113

FIGURE 34 PERKINELMER, INC.: COMPANY SNAPSHOT (2016) 116

FIGURE 35 EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT (2016) 119

FIGURE 36 MACROGEN, INC.: COMPANY SNAPSHOT (2015) 125

FIGURE 37 QIAGEN N.V.: COMPANY SNAPSHOT (2016) 127

FIGURE 38 TAKARA BIO INC.: COMPANY SNAPSHOT (2016) 136

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

127826 | BT 5526

Number of Pages

159

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
NPS+ Type 2 Diabetes Mellitus (US)
IntroductionT2DM drug manufacturers: compare your brand to 7 major competitorsHow loyal are doctors ...
01 Dec 2015 by FirstWord Pharma USD $2,495 More Info
NPS+ Type 2 Diabetes Mellitus (EU5)
IntroductionT2DM drug manufacturers: Compare your brand to 7 major competitorsHow loyal are doctors ...
01 Dec 2015 by FirstWord Pharma USD $2,495 More Info
Medical Affairs Reputations (US): Type 2 Diabetes Mellitus
IntroductionWhat do physicians think of U.S. Medical Affairs teams in the Type 2 Diabetes Mellitus (...
01 Sep 2015 by FirstWord Pharma USD $5,995 More Info
Medical Affairs Reputations (EU5): Type 2 Diabetes Mellitus
IntroductionWhat do physicians think of Europe Medical Affairs teams in the Type 2 Diabetes Mellitus...
01 Sep 2015 by FirstWord Pharma USD $5,995 More Info
Type 2 Diabetes Mellitus: KOL Insight
IntroductionThe market for Type 2 Diabetes therapies is extremely crowded. Several classes, includin...
01 Jul 2015 by FirstWord Pharma USD $7,900 More Info
FirstView Barriers – An Analysis of Market Barriers in Type 2 Diabetes (US)
IntroductionWhat environmental market barriers are influencing the Type 2 Diabetes (T2DM) market? F...
20 Apr 2015 by FirstWord Pharma USD $4,995 More Info
FirstView Barriers – An Analysis of Market Barriers in Type 2 Diabetes (EU5)
IntroductionWhat market barriers are influencing the Type 2 Diabetes (T2DM) market? From price to a...
20 Apr 2015 by FirstWord Pharma USD $4,995 More Info
Physician Views: Will next-generation long-acting insulins prove compelling?
Scope In the second of two diabetes-focused Physician Views polls being run by FirstWord Pharma PLUS...
19 Nov 2014 by FirstWord Pharma USD $695 More Info
Physician Views - Breathing new life into patient care; patient-centric services in the respiratory market
Scope According to the Institute of Medicine, patient-centric care can be defined as "providing care...
08 Apr 2014 by FirstWord Pharma USD $695 More Info
Physician Views: Can GlaxoSmithKline strike early with Anoro? / What role will dosing, inhaler type play in uptake of LAMA/LABA combinations for COPD?
ScopeThis year looks set to be one of notable evolution for the US chronic obstructive pulmonary dis...
01 Aug 2013 by FirstWord Pharma USD $695 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Next-Generation Sequencing (NGS) Services Market by Type (Targeted, RNA-Seq, Exome, De Novo), Technology (Sequencing by Synthesis, Ion semiconductor, SMRT, Nanopore), & Application (Diagnostics, Oncology, Drug Discovery, Agriculture) - Forecasts to 2022 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...